Amrize Ltd
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Revenue | $11.8B | $11.7B | $11.7B |
| Gross profit | $3.0B | $3.1B | $2.8B |
| Operating income | $1.9B | $2.2B | $1.9B |
| Cost of revenue | $8.8B | $8.6B | $8.9B |
| Cash from operations | $2.2B | $2.3B | $2.0B |
| Capital expenditure | $788.0M | $642.0M | $630.0M |
| Free cash flow | $1.4B | $1.6B | $1.4B |
| Impairments | $15.0M | $2.0M | $15.0M |
| Total assets | $24.2B | $23.8B | — |
| Total liabilities | $11.0B | $13.9B | — |
| Total debt | $5.3B | — | — |
Shares outstanding 553.5M · Free float 99.5%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.